1.5 Abstract in rivista: [1906] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 1.906
Titolo Data di pubblicazione Autore(i) File
Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting 1-gen-2016 Siano, ; Infante, ; Miceli, ; Resteghini, C; Locati, ; Licitra, ; Bossi,
A retrospective cohort study of PD-L1 expression in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SUPREME-HN). 1-gen-2017 Pai, ; Sara, I.; Cohen, ; Ezra, ; Lin, ; Derrick, ; Fountzilas, ; George, ; Kim, ; Edward, S.; Mehlhorn, ; Holger, ; Baste, ; Neus, ; Clayburgh, ; Daniel, ; Lipworth, ; Loren, ; Resteghini, C; Shara, ; Nawar, ; Fujii, ; Takashi, ; Zhang, ; Jun, ; Stokes, ; Michael, ; Lawrence, ; David, ; Khaliq, ; Asud, ; Melillo, ; Giovanni, ; Shire, ; Norah,
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic (R/M) squamous cell carcinoma of the head and neck (SUPREME-HN) 1-gen-2018 Pai, ; Cohen, ; E. E., W.; Lin, ; Fountzilas, ; Kim, ; Mehlhorn, ; Baste, ; Clayburg, ; Lipworth, ; Resteghini, C; Shara, ; Fujii, ; Zhang, ; Stokes, ; Lawrence, ; Khaliq, ; Melillo, ; Shire,
Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients 1-gen-2021 Corino, ; Valentina, ; Colombo, ; Elena, ; Bologna, ; Marco, ; Calareso, ; Giuseppina, ; Mainardi, ; Luca, ; Cavalieri, ; Stefano, ; Filippini, ; Daria, Maria; Resteghini, C; Bergamini, ; Cristiana, ; Licitra, ; Lisa, F.; Locati, ; Laura, Deborah
BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment 1-gen-2022 Cavalieri, ; Vener, ; Leblanc, ; Perez, ; L., Lopez; Fico, ; Resteghini, C; Monzani, ; Marton, ; Moreira-Soares, ; Filippidou, ; D., E.; Almeida, ; Bilbao, ; Mehanna, ; Singer, ; Thomas, ; Lacerenza, ; Manfuso, ; Mercalli, ; Martinelli, ; Licitra, ; L., F.
Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) 1-gen-2019 Alfieri, ; Salvatore, ; Ferrara, ; Roberto, ; Calareso, ; Giuseppina, ; Cavalieri, ; Stefano, ; Platini, ; Francesca, ; Mancinelli, ; Moela, ; Resteghini, C; Orlandi, ; Ester, ; Iacovelli, ; Nicola, Alessandro; Ferella, ; Letizia, ; Piazza, ; Cesare, ; Apollonio, ; Giulia, ; Galbiati, ; Donata, ; Bossi, ; Paolo, ; Bergamini, ; Cristiana, ; Locati, ; Laura, Deborah; Licitra, ; Lisa, F.
A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma 1-gen-2017 Bossi, ; Cavalieri, ; Perrone, ; Miceli, ; Ascierto, ; Locati, ; Bergamini, ; Granata, ; Alfieri, ; Resteghini, C; Galbiati, ; Busico, ; Paielli, ; Patuzzo, ; Maurichi, ; Gallino, ; Ruggeri, ; Mariani, ; Palla, ; Licitra,
Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC). 1-gen-2017 Bossi, ; Paolo, ; Cavalieri, ; Stefano, ; Perrone, ; Federica, ; Miceli, ; Rosalba, ; Ascierto, ; Paolo, Antonio; Locati, ; Laura, D.; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Alfieri, ; Salvatore, ; Resteghini, C; Galbiati, ; Donata, ; Busico, ; Adele, ; Paielli, ; Nicholas, ; Patuzzo, ; Roberto, ; Maurichi, ; Andrea, ; Gallino, ; Gianfranco, ; Ruggeri, ; Roberta, ; Mariani, ; Luigi, ; Palla, ; Marco, ; Licitra, ; Lisa,
Retrospective analysis of baseline clinical factors associated to CDDP-nephrotoxicity in locally advanced head and neck cancer (LAHNC) patients 1-gen-2019 Platini, ; Francesca, ; Barretta, ; Francesco, ; Alfieri, ; Salvatore, ; Cavalieri, ; Stefano, ; Resteghini, C; Galbiati, ; Donata, ; Locati, ; Laura, Deborah; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Calareso, ; Giuseppina, ; Iacovelli, ; Nicola, Alessandro; Quattrone, ; Pasquale, ; Incandela, ; Fabiola, ; Bossi, ; Paolo, ; Licitra, ; Lisa, F.
Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer 1-gen-2017 Granata, ; Orlandi, ; Infante, ; Iacovelli, ; N., A.; Miceli, ; Cavallo, ; Alfieri, ; Bergamini, ; Resteghini, C; Galbiati, ; Cavalieri, ; Locati, ; Tana, ; Naimo, ; Fallai, ; Licitra, ; Bossi,
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN) 1-gen-2017 Pai, ; Cohen, ; E., E.; Lin, ; Fountzilas, ; Kim, ; E., S.; Mehlhorn, ; Baste, ; Clayburgh, ; Lipworth, ; Resteghini, C; Shara, ; Fujii, ; Zhang, ; Stokes, ; Lawrence, ; Khaliq, ; Melillo, ; Shire,
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 1-gen-2019 De, Cecco; Serafini, ; M., S.; Canevari, ; Penso, ; Nicolai, ; Castelnuovo, ; Benazzo, ; Sponghini, ; Orlandi, ; Vischioni, ; Piazza, ; Resteghini, C; Licitra, ; Bossi,
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 1-gen-2021 Resteghini, C; Castelnuovo, ; Paolo, ; Nicolai, ; Piero, ; Orlandi, ; Ester, ; Bossi, ; Paolo, ; Vischioni, ; Barbara, ; Schreiber, ; Alberto, ; Iacovelli, ; Nicola, Alessandro; Battaglia, ; Paolo, ; Mattavelli, ; Davide, ; Facchinetti, ; Nadia, ; Gambazza, ; Simone, ; Calareso, ; Giuseppina, ; Ravanelli, ; Marco, ; Facco, ; Carla, ; Tartaro, ; Tiziana, ; Sponghini, ; Andrea, Pietro; Pagella, ; Fabio, ; Mariani, ; Luigi, ; Licitra, ; Lisa, F.
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience 1-gen-2016 Granata, ; Bossi, ; Bergamini, ; Alfieri, ; Resteghini, C; Galbiati, ; Orlandi, ; Iacovelli, ; N., A.; Fallai, ; Guzzo, ; Infante, ; Locati, ; Miceli, ; Mariani, ; Licitra,
Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer 1-gen-2017 Orlandi, ; Infante, ; Granata, ; Iacovelli, ; Miceli, ; Cavallo, ; Alfieri, ; Bergamini, ; Resteghini, C; Galbiati, ; Locati, ; Tana, ; Naimo, ; Fallai, ; Licitra, ; Bossi,
BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure 1-gen-2020 Platini, ; Francesca, ; Ortolan, ; Elisa, ; Cavalieri, ; Stefano, ; Massa, ; Giacomo, ; Filippini, ; Daria, Maria; Alfieri, ; Salvatore, ; Bergamini, ; Cristiana, ; Resteghini, C; Orlandi, ; Ester, ; Paolini, ; Biagio, ; Piazza, ; Cesare, ; Perrone, ; Federica, ; Tamborini, ; Elena, ; Ferrarini, ; Linda, ; Serafini, ; Mara, Serena; Cappelletti, ; Vera, ; Daidone, ; Maria, Grazia; Licitra, ; Lisa, F.; Locati, ; Laura, Deborah
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area 1-gen-2017 Cavallo, ; Cicchetti, ; Iacovelli, ; N., A.; Alessi, ; Padovano, ; Colombo, ; Facchinetti, ; Alfieri, ; Bossi, ; Resteghini, C; Licitra, ; Fallai, ; Crippa, ; Rancati, ; Pignoli, ; Orlandi,
Sinonasal non-glandular cancers relapsing after multimodal treatments 1-gen-2017 Cavalieri, ; Granata, ; Locati, ; L., D.; Bergamini, ; Alfieri, ; Resteghini, C; Galbiati, ; Orlandi, ; Iacovelli, ; N., A.; Calareso, ; Guzzo, ; Quattrone, ; Licitra, ; Bossi,
Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial 1-gen-2022 Bossi, ; Paolo, ; Alberti, ; Andrea, ; Bergamini, ; Cristiana, ; Resteghini, C; Locati, ; Laura, Deborah; Alfieri, ; Salvatore, ; Cavalieri, ; Stefano, ; Colombo, ; Elena, ; Gurizzan, ; Cristina, ; Lorini, ; Luigi, ; Tovazzi, ; Valeria, ; Zamparini, ; Manuel, ; Ravanelli, ; Marco, ; Ascierto, ; Paolo, Antonio; Rampinelli, ; Vittorio, ; Grammatica, ; Alberto, ; Patuzzo, ; Roberto, ; Maurichi, ; Andrea, ; Licitra, ; Lisa, F.
Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration 1-gen-2022 Trama, ; Matsuda, ; Charvat, ; Chiang, ; R. R., C-J.; Van, Gestel; A., J.; Martin, ; Geleijnse, ; Bonfarnuzzo, ; Licitra, ; L., F.; Cavalieri, ; Resteghini, C; Gatta, ; Botta,
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 1.906
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista1906
Autore
  • LEVI SETTI, PAOLO EMANUELE72
  • ASSELTA, ROSANNA68
  • DUGA, STEFANO63
  • UCCELLA, SILVIA62
  • GATTI, Roberto60
  • Cento, Valeria56
  • MUTO, Giovanni47
  • FRANZESE, Ciro45
  • TORZILLI, Guido44
  • DANESE, Silvio42
Data di pubblicazione
  • 2020 - 202386
  • 2010 - 20191197
  • 2000 - 2009511
  • 1990 - 1999111
  • 1988 - 19891
Editore
  • Nature Publishing Group4
  • s.n4
  • ICRS3
  • Blackwell1
Rivista
  • EUROPEAN UROLOGY. SUPPLEMENTS124
  • GASTROENTEROLOGY121
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...119
  • THE JOURNAL OF UROLOGY110
  • DIGESTIVE AND LIVER DISEASE96
  • THE JOURNAL OF NUCLEAR MEDICINE81
  • RADIOTHERAPY AND ONCOLOGY56
  • ANNALS OF ONCOLOGY46
  • HEPATOLOGY43
  • JOURNAL OF CLINICAL ONCOLOGY43
Keyword
  • Myelodysplastic syndrome8
  • Survival4
  • biomimetic3
  • Mitochondrial ferritin3
  • osteochondral3
  • Prognosis3
  • scaffold3
  • Sideroblastic anemia3
  • viscosupplementation3
  • classification2
Lingua
  • eng611
  • ita24
  • und6
Accesso al fulltext
  • no fulltext1854
  • reserved50
  • open2